Your daylight saving time medication schedule depends on what the prescription follows: bedtime, a clock hour, or days between doses. Weekly injections generally have more timing room than medicines or devices tied to particular hours. Any change to a prescribed schedule belongs with the prescriber, including a change prompted by the clocks.

Daylight saving time medication schedule: what changes

As of October 29, 2026, the day this article was written, NIST confirms that daylight saving time ends Sunday, November 1, 2026. At 2 a.m. local time, clocks move back to 1 a.m. The rule is the first Sunday in November. Hawaii, most of Arizona, Puerto Rico, Guam, American Samoa and the U.S. Virgin Islands keep their clocks unchanged; the Navajo Nation in Arizona observes the change.

The repeated hour makes one day longer. From 9 p.m. Saturday to 9 p.m. Sunday is 25 real hours, not 24. Whether that extra hour matters depends on the medicine.

For a daily tablet, the useful question is whether its directions allow that timing flexibility. A bedtime prescription raises another question: does the written plan follow sleep, or a fixed clock hour? A pharmacist can explain the directions, and the prescriber settles any change.

Bedtime prescriptions: what does the time mean?

Bedtime and 9 p.m. aren't necessarily the same thing after the change, especially for someone working nights. A prescription tied to sleep needs that distinction made clear.

Sermorelin copies growth hormone-releasing hormone, a signal that prompts growth-hormone release. In Khorram and colleagues' 1997 study in the Journal of Clinical Endocrinology & Metabolism, participants received a related, modified hormone nightly at 9 p.m. It wasn't sermorelin itself, and the study didn't test a clock change. That schedule is a trial fact, not a new bedtime instruction.

The guide to when sermorelin is taken explains the usual bedtime convention. During fall back, the prescriber can clarify what the existing directions mean for the person's actual sleep period. There isn't a study-backed, one-hour adjustment rule to borrow from that old trial.

A compounded medicine is prepared by a pharmacy for an individual prescription. Compounded sermorelin is not FDA-approved; an FDA-approved sermorelin product was once marketed and has since been discontinued (FDA's Geref record).

Does the time change affect a weekly injection?

The branded weekly injections allow flexibility in time of day. Their rules for changing days or handling a missed dose differ, though. Zepbound contains tirzepatide; Ozempic and Wegovy contain semaglutide.

As of October 29, 2026, the day this article was written, the Zepbound label reads “Revised: 08/2026”; Ozempic reads “Revised: 5/2026”; and Wegovy reads “Revised: 06/2026.” These are their injection-label timing rules:

Branded medicine Changing the weekly day One missed injection
Zepbound Doses separated by “at least 3 days (72 hours)” A catch-up window “within 4 days (96 hours)” after the missed dose; after that, the label describes skipping it
Ozempic The label specifies “at least 2 days (>48 hours)” between doses A catch-up window within 5 days after the missed dose; after that, the label describes skipping it
Wegovy Its medication guide allows a day change when the last dose was “2 or more days before” The next dose being more than 48 hours away allows a catch-up dose; less than 48 hours away means the missed dose is skipped

Those windows explain why a one-hour fall change alone generally doesn't require moving the weekly day. They don't replace an individual's prescription. Compounded preparations follow the prescriber's schedule and the dispensing pharmacy's directions.

Tirzepatide and semaglutide prescribed through Promise are dispensed by a licensed U.S. compounding pharmacy as compounded medications, which are different from an FDA-approved product: the formulations offered here are not FDA-approved. FDA explains that distinction. A licensed provider may still prescribe — that decision is between you and your doctor.

Crossing time zones adds separate questions, covered in flying with tirzepatide.

Pumps, glucose monitors and smart pens have their own clocks

A phone showing the right hour doesn't establish that every connected device has updated.

  • Insulin pumps: These devices deliver insulin. Tandem's t:slim X2 guidance describes adjusting the pump clock for daylight saving time so insulin delivery follows the intended schedule.
  • Glucose monitors: A continuous glucose monitor, or CGM, tracks blood sugar. The Dexcom G7 guide calls for automatic phone time updates and cautions against manually changing the phone clock.
  • Smart pens: These record insulin doses. InPen's manufacturer says the phone's current time matters for manual dose records and estimates of insulin still active in the body.

This matters for someone prescribed both a weekly medicine and insulin. The Zepbound label also describes increased low-blood-sugar risk alongside insulin or a sulfonylurea, a type of diabetes medicine. Device-specific instructions and the diabetes team's plan address a different issue from changing the weekly injection day.

Fall sleep changes and DSIP

An extra hour on the clock doesn't guarantee an extra hour asleep. The American Academy of Sleep Medicine's 2020 position statement describes more immediate health risks in spring, while noting sleep disruption with both transitions. Its 2024 update says the fall change has also been associated with disrupted sleep, mood disturbance, patient-safety incidents, suicide and traffic accidents.

As of October 29, 2026, the day this article was written, a study posted October 11 reports shifts in sleep timing around both changes. Researchers used Fitbit data from 1,522 adults; fall sleep timing moved about 28 minutes earlier relative to the Arizona comparison. This is a preprint, a study shared before a journal's independent expert review. It didn't test medication schedules.

DSIP, short for delta sleep-inducing peptide, is a short chain of protein building blocks studied for sleep. No published human study has tested DSIP around daylight saving time changes. A 1992 double-blind study of 16 people with chronic insomnia found only weak effects and no change in reported sleep quality, after smaller earlier studies had reported better sleep measures. DSIP is not FDA-approved. The DSIP evidence guide and sermorelin sleep review explain what the sleep studies actually found. A clock change doesn't establish a reason to add either medicine or alter a prescription.

What a provider can settle before Sunday

A useful conversation starts with the actual prescription, the last dose time, the usual sleep period and any insulin devices. The prescriber can clarify the intended interval and how the plan handles a genuinely missed dose. The pharmacy can clarify wording on the dispensing label.

At Promise, a licensed provider reviews every request, and not everyone qualifies. The actual dose and schedule come from that clinical review.